Webinar: Continuity in uncertain times: MHRA Brexit provisions

The Medicines & Healthcare products Regulatory Agency (MHRA) is working closely with the Government to analyse the best options and opportunities available for the safe and effective regulation of medicines and medical devices in the UK.

In this webinar, Dr Christiane Niederlaender will discuss the provisions the MHRA is putting in place to prepare for the UK's departure from the EU.

Topics covered during the webinar will include:

  • MHRA preparations  for different outcomes of the UK Brexit negotiations 
  • The regulatory framework for the event of a no deal scenario
  • Options for ‘in-flight’ applications
  • New assessment time frames and opportunities
  • Alignment with Europe

The 45-minute presentation will be followed by a 15-minute Q&A session with the speakers.

Register here

Discover who we are